EARLY SERUM HEPATITIS B VIRUS LARGE SURFACE PROTEIN LEVEL: A STRONG PREDICTOR OF VIROLOGICAL RESPONSE FOR PEGINTERFERON, BUT NOT FOR ENTECAVIR, IN HBeAg-POSITIVE CHRONIC HEPATITIS B

被引：0
作者：
Zhu, X. J. [1 ]
Gong, Q. M. [1 ]
Yu, D. M. [1 ]
Zhang, D. H. [1 ]
Gu, L. L. [1 ]
Han, Y. [1 ]
Chen, J. [1 ]
Zhang, X. X. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Dept Infect Dis, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60785-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
783
引用
收藏
页码：S319 / S319
页数：1
相关论文
共 50 条
[21]   HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B [J].
Fried, Michael W. ;
Piratvisuth, Teerha ;
Lau, George K. K. ;
Marcellin, Patrick ;
Chow, Wan-Cheng ;
Cooksley, Graham ;
Luo, Kang-Xian ;
Paik, Seung Woon ;
Liaw, Yun-Fan ;
Button, Peter ;
Popescu, Matei .
HEPATOLOGY, 2008, 47 (02) :428-434
[22]   Response-guided peginterferon therapy for hbeag-positive and hbeag-negative chronic hepatitis b using hepatitis b surface antigen levels: A review [J].
Sonneveld M.J. ;
Brouwer W.P. ;
Janssen H.L.A. .
Current Hepatology Reports, 2014, 13 (3) :250-255
[23]   Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B [J].
Peng, C. -Y. ;
Lai, H. -C. ;
Li, Y. -F. ;
Su, W. -P. ;
Chuang, P. -H. ;
Kao, J. -T. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (04) :458-468
[24]   Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B [J].
Sonneveld, Milan J. ;
Arends, Pauline ;
Boonstra, Andre ;
Hansen, Bettina E. ;
Janssen, Harry L. A. .
JOURNAL OF HEPATOLOGY, 2013, 58 (05) :898-903
[25]   Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B [J].
Sherman, Morris ;
Yurdaydin, Cihan ;
Sollano, Jose ;
Silva, Marcelo ;
Liaw, Yun-Fan ;
Cianciara, Janusz ;
Boron-Kaczmarska, Anna ;
Martin, Paul ;
Goodman, Zachary ;
Colonno, Richard ;
Cross, Anne ;
Denisky, Gail ;
Kreter, Bruce ;
Hindes, Robert .
GASTROENTEROLOGY, 2006, 130 (07) :2039-2049
[26]   Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients [J].
Bradshaw, D. ;
Danta, M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (09) :992-992
[27]   Response-guided peginterferon therapy in HBeAg-positive chronic hepatitis B using serum hepatitis B surface antigen levels: a pooled analysis of 803 patients [J].
Sonneveld, Milan J. ;
Hansen, Bettina E. ;
Piraivisuth, Teerha ;
Jia, Jidong ;
Zeuzem, Stefan ;
Gane, Edward J. ;
Liaw, Yun-Fan ;
Xie, Qing ;
Heathcote, E. Jenny ;
Chan, Henry Lik-Yuen ;
Janssen, Harry L. .
HEPATOLOGY, 2012, 56 :202A-202A
[28]   PREDICTION OF RESPONSE TO PEGINTERFERON FOR HBEAG-POSITIVE CHRONIC HEPATITIS B USING QUANTITATIVE SEROLOGY: HBEAG VERSUS HBSAG [J].
Sonneveld, M. J. ;
Rijckborst, V. ;
Hansen, B. E. ;
Janssen, H. L. .
JOURNAL OF HEPATOLOGY, 2012, 56 :S215-S216
[29]   Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B [J].
Gish, Robert G. ;
Lok, Anna S. ;
Chang, Ting-Tsung ;
De Man, Robert A. ;
Gadano, Adrian ;
Sollano, Jose ;
Han, Kwang-Hyub ;
Chao, You-Chen ;
Lee, Shou-Dong ;
Harris, Melissa ;
Yang, Joanna ;
Colonno, Richard ;
Brett-Smith, Helena .
GASTROENTEROLOGY, 2007, 133 (05) :1437-1444
[30]   Effects of telbivudine and entecavir for HBeAg-positive chronic hepatitis B: A meta-analysis [J].
Su, Qi-Min ;
Ye, Xiao-Guang .
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (43) :6290-6301
12345